Merge Communications (@MergeComm) header
Merge Communications (@MergeComm) profile picture

Creativity in patient recruitment. Uncovering patient truths. Making study teams happy campers. Those are a few of our favorite things.

Raleigh, NC
Joined January 2017
Photo by Merge Communications (@MergeComm)Photo by Merge Communications (@MergeComm)Photo by Merge Communications (@MergeComm)Photo by Merge Communications (@MergeComm)Photo by Merge Communications (@MergeComm)Photo by Merge Communications (@MergeComm)Photo by Merge Communications (@MergeComm)Photo by Merge Communications (@MergeComm)Photo by Merge Communications (@MergeComm)Photo by Merge Communications (@MergeComm)
A recent study explored an unexpected tool to reach patients: Cameo. Internet personalities were selected to create promos for clinical trials, which resulted in a simple & cost-effective way to connect with more audiences. Read more about the approach: bit.ly/4rFEvWw
5
Merge Clinical Study Communications speeds relief to sites – accelerating timelines and maximizing budgets. mergellc.com
1
Here’s hoping your study is all treats and no tricks! Happy Halloween! 👻 🦇 🎃
2
Early education & community outreach may be key to connecting patients with trials earlier & organically. Consistently hosting community events helps sites build trust, strengthen relationships & foster engagement with potential participants. More info: bit.ly/4ADR60N
Merge Clinical Study Communications developed a highly effective tool for reporting pre-identified patients – in under 6 weeks, in 38 countries, with no technical issues. Learn more. mergellc.com/
Patient advocacy organizations are an underutilized resource that can strengthen relationships between patients & trial sites. This case study by @ErgomedPLC shares a step-by-step guide to establishing, growing & effectively integrating PAOs in trials. bit.ly/4huIP6w
1
Keep your study top-of-mind with all study stakeholders. Learn more about Brandbuilder – from Merge Clinical Study Communications. mergellc.com/
2
Merge Clinical Study Communications excels at media strategy, planning and placement – in traditional media – and in online, mobile and social media – nationally, and globally. mergellc.com/
5
Rare disease trials are critical to advancing care, but they face their own unique challenges. This article explores 7 of the most common obstacles & more importantly, offers actionable solutions to overcome them. Read the solution-focused approach here: bit.ly/47x5Z7u
1
Is trial recruitment focused on the wrong thing? The biggest challenge isn’t getting patients to participate—it’s getting patients and trials to find each other! Recruiting the right patients starts with connecting them to the right opportunities. Read on: bit.ly/4qCktMg
1
Merge turns a struggling study into a success with targeted tactics. Read case study. mergellc.com/
1
Stimulate stagnant studies. Learn about problem-solving specialties from Merge Clinical Study Communications. mergellc.com
1
Merge Clinical Study Communications is committed to patient research. Looking for a simple, affordable and fast solution? Discover Study Snapshot. mergellc.com
2
#WorldPatientSafetyDay calls attention to the importance of clear communication, informed participation, and patient-centered designs in clinical trials and research. When patients are better informed, they’re better equipped to make decisions about their healthcare journey.🌍🤲
1
To maintain subject interest in a two-year Perennial Allergic Rhinitis study, we created a robust subject retention kit to supplement the ongoing recruitment program. Read more. mergellc.com/
1
This #LaborDay, we want to honor the people behind the progress. We celebrate the dedication and hard work of those advancing healthcare and making a difference in the lives of others.
2
Expanding access to clinical trials starts with meeting patients where they are. New partnerships bring research closer to local communities using tech & innovative prescreening approaches to help eligible patients find trial opportunities. Read on: bit.ly/4irrHjZ
Recent advances in EU trial regulation now “requires that the people enrolled in trials reflect the populations likely to use a medicine.” This initiative aims to expand gender representation, accurately portray demographics & improve women’s healthcare. bit.ly/4b0HPVk
1